PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

Podcast: Change Your Behaviors, Change Your Health & Wellness—Jennifer Turgiss, VP Behavior Science & Advanced Analytics, J&J

Proposed Rule to Eliminate Pharmaceutical Rebates Raises Challenging Questions

eyeforpharma Awards 2019: Nominations Open
Top Story
Have We Reached a Watershed on Transparency and International Collaboration in Drug Pricing?
The World Health Assembly's new resolution on transparency in the market for health-related products is weaker than the original draft but still contains measures that could have a substantial impact on market access around the world, writes Neil Grubert
… /Read more/
Advertisement
Deloitte's 2019 Life Sciences accounting and financial reporting update
Insights on new accounting standards and more
A year of major change for life sciences companies is underway. Deloitte's latest update on life sciences financial reporting explains what accounting departments need to know to keep up in a rapidly evolving environment.
Download the full report here
ADVERTISEMENT

Pricing
A New Pricing Paradigm: Increasing Competition
In the first in a series of articles addressing each of the American Patients First blueprint's four strategies, Rick Kelly and Nisha Desai focus on "Increasing Competition"
… /Read more/
Advertisement
AI-powered Biomedical Literature Discovery supporting Science-based Business Decisions
On Demand
Learn More
Strategy
Making the Most of Maturing Oncology Brands
A ten-item checklist of cost-effective best practices for the often-overlooked mid-life products, five or so years after launch.
… /Read more/
 
FDA
Advancing Non-Prescription Medicines, Including CBD Products
Jill Wechsler looks at the proposed new FDA rules to beef up regulatory resources and promote digital technologies to support the development and marketing of safe and innovative over-the-counter therapies
… /Read More/
 
Video
eyeforpharma Barcelona: Speaker Interviews
Pharm Exec sat down with a host of speakers at this year's eyeforpharma Barcelona—including Kris Sterkens, Group Chairman, EMEA, Janssen; Gitta Aabo, CEO, LEO Pharma; and Paul Jones, Director of Population Genomics at Illumina—to get their insights on the hot topics of the moment
… /Click here to watch/

Calendar
/ June 13–14: Rare Disease Innovation and Partnering Summit /
Boston, MA
/ June 14–15: 13th World Drug Delivery Summit /
Montreal, Canada
/ June 23–27: DIA 2019 /
San Diego, CA
/ July 8–9: Leadership for Drug Development Teams /
Boston, MA
/ August 8–9: Direct-to-Patient Clinical Trials /
Philadelphia, PA
/ September 10–11: 5th Annual Bio/Pharmaceutical Product Launch Summit /
Cambridge, MA
/ November 13–14: 6th Annual Global Compliance Congress /
London, UK
/ December 11: eyeforpharma Awards 2019 /
Philadelphia, PA.

Industry update
//Aptose Biosciences (San Diego, CA and Toronto, Canda) appointed Jotin Marango, M.D., Ph.D., as Senior Vice President, Chief Business Officer. // Zai Lab Limited (San Francisco, CA and Shanghai, China) named Valeria Fantin, Ph.D. as Chief Scientific Officer. // Syneos Health (Morrisville, NC) appointed Patrick Nealon as Executive Vice President and General Manager of Oncology Clinical Development. // RedHill Biopharma appointed June Almenoff, M.D., Ph.D., FACP, as Chief Scientific Officer. // CSL (King of Prussia, PA) named Dr. Paul McKenzie as Chief Operating Officer.
advertise with us / print subscribe / digital subscribe / visit pharmexec.com